|Day's Range||49.06 - 49.24|
|52 Week Range||31.47 - 49.42|
|PE Ratio (TTM)||-70.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval. Highly anticipated tax reforms are being delayed by the ongoing healthcare policy debate.
Troubles at a plant acquired with St. Jude and continuing risks to closing the Alere deal linger over M&A spree.
Sales grew 29.7% in a year marked by acquisitions and new products, while comparable operations sales grew 3.2%.